E
BioNTech SE BNTX
$105.07 -$5.81-5.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 7.44% 0.51% -27.67% -52.12% -69.09%
Total Other Revenue -- -- -- -- --
Total Revenue 7.44% 0.51% -27.67% -52.12% -69.09%
Cost of Revenue 26.88% -0.26% -9.92% -19.55% -59.44%
Gross Profit 3.43% 0.71% -30.99% -55.47% -70.54%
SG&A Expenses -11.02% 2.72% 7.41% 12.40% 15.04%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 323.07% 243.64% 238.50% 174.70% -955.38%
Total Operating Expenses 17.86% 49.77% 63.20% 34.95% -1.95%
Operating Income -86.48% -2,339.61% -196.36% -111.61% -107.37%
Income Before Tax -61.72% -650.71% -157.56% -108.92% -104.42%
Income Tax Expenses -117.38% -181.54% -105.44% -83.24% -82.16%
Earnings from Continuing Operations 29.76% -786.05% -171.78% -117.67% -112.20%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 29.76% -786.05% -171.78% -117.67% -112.20%
EBIT -86.48% -2,339.61% -196.36% -111.61% -107.37%
EBITDA -105.15% -598.51% -170.23% -106.99% -104.34%
EPS Basic 29.71% -772.17% -172.03% -117.83% -112.22%
Normalized Basic EPS -52.09% -451.17% -146.86% -106.13% -103.27%
EPS Diluted 29.88% -810.16% -173.18% -118.28% -112.77%
Normalized Diluted EPS -47.68% -466.27% -147.62% -106.39% -103.52%
Average Basic Shares Outstanding 0.36% 0.17% -0.03% -0.41% -0.66%
Average Diluted Shares Outstanding 0.16% -0.03% -0.47% -0.91% -2.28%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --